id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S17647 R74531 |
Berard (150 mg), 2019 | Major congenital malformation (according ICD-9 and 10) | 1st trimester | nested case control | unexposed (general population or NOS) | Adjustment: Yes | 1.08 [0.87;1.34] | 92/913 19,396/225,686 | 19,488 | 913 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17642 R74416 |
Molgaard-Nielsen (150 mg), 2013 | Major birth defects | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 0.99 [0.82;1.20] | 107/4,082 25,159/968,236 | 25,266 | 4,082 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17653 R74568 |
Jick (92% received the single 150-mg dose preparation), 1999 | Congenital anomaly | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 1.07 [0.37;3.10] C | 4/234 26/1,629 | 30 | 234 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.03 [0.89;1.19] | 44,784 | 5,229 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: 150 mg; 2: 150 mg; 3: 92% received the single 150-mg dose preparation;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded